Tuesday, October 17, 2017

Illumina Ventures Raises $230M Venture Capital Fund

Illumina Ventures, the early-stage venture capital investor which was founded by San Diego-based life sciences equipment maker Illumina, says it has raised $230M for its first fund. The venture capital investment fund said it is focused on genomics, and will invest in companies in the areas of life science research, clinical diagnostics, novel therapeutic platforms, and other technologies impacting human health. The fund launched in summer of 2016 with $100M from Illumina. The venture investment fund was founded by Nicholas Naclerio, Ph.D., the former SVP of Corporate and Venture Development for Illumina, and is based in San Francisco.

---